Beranda › Kanker Pankreas › Montana
Uji klinis Kanker Pankreas di Montana
6 studi untuk Kanker Pankreas mencari peserta di lokasi di Montana.
Kota di Montana
Teks studi resmi (Bahasa Inggris)
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
- Saint Joseph Hospital - Cancer Centers - St. Vincent Frontier Cancer Center, Billings
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07409272Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
- Saint Patrick Hospital - Community Hospital, Missoula
Menerima pesertaStudi observasional
Usia 50 hingga 75 · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT04239573Integrated Cancer Repository for Cancer Research
- Bozeman Health Deaconess Hospital, Bozeman
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 19 hingga 110 · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT02012699Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
- Community Hospital of Anaconda, Anaconda
- Billings Clinic Cancer Center, Billings
- Bozeman Health Deaconess Hospital, Bozeman
- dan 7 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Mei 2026 · NCT06998940A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
- Ohio State University-Telemedicine, Bozeman
- Ohio State University Telemedicine, Miles City
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Feb 2026 · NCT06906562SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Billings
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 28 Okt 2025 · NCT03452774Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.